Should we be attempting to control myopia progression in a clinical setting? And,if so, what are the options?

Results and analysis of a randomised controlled trial of an alternative model of glaucoma care by optometrists.

In this article we will outline the importance of developing standards for affordable and accessible low-vision service delivery that can be applied globally and that are relevant to both the developed and developing world.